Partnervest Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

Partnervest Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,007	Closed	-$53K	–	723
2014 Q2	$53K	Hold	1,007	–	–	0.02%	356
2014 Q1	$53K	Buy	1,007 +1	+0.1%	+$46	0.02%	321
2013 Q4	$40K	Hold	1,006	–	–	0.02%	345
2013 Q3	$38K	Buy	1,006 +1	+0.1%	+$39	0.02%	326
2013 Q2	$39K	Buy	+1,005	New	+$39.1K	0.02%	288

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Partnervest Advisory Services's TEVA Position: Q3 2014 in Review

Partnervest Advisory Services sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 1,007 shares — an estimated $53K sold.

Partnervest Advisory Services first reported a position in TEVA in Q2 2013 and held it in 5 quarters. The position peaked at $53K in Q2 2014. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

Partnervest Advisory Services reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
Partnervest Advisory Services sold 1,007 Teva Pharmaceuticals shares in Q3 2014, an estimated $53K.
Partnervest Advisory Services first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Partnervest Advisory Services's Teva Pharmaceuticals position peaked at $53K in Q2 2014.
772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Partnervest Advisory Services's 13F filing for Q3 2014, filed 7 Nov 2014.